ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
August 04, 2022 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
July 27, 2022 20:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, July 27, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
July 07, 2022 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
May 19, 2022 08:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 19, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022
May 12, 2022 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 12, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022
May 10, 2022 10:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 10, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
May 05, 2022 13:18 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- Certain immaterial corrections have been made to the second and fifth paragraphs. ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
May 05, 2022 11:17 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
April 11, 2022 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, April 11, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
February 22, 2022 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Feb. 22, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...